Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.
Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback